Copaxone and Breastfeeding
No studies have been conducted on Copaxone (glatiramer acetate) and breastfeeding, so it is not known whether the drug passes through breast milk. Since the medication is a rather large molecule, however, it is unlikely to pass through breast milk. If you are taking Copaxone and breastfeeding (or thinking of breastfeeding), talk to your healthcare provider about the benefits and possible risks.
Copaxone® (glatiramer acetate) is an injectable prescription medication approved for the treatment of multiple sclerosis. Because the risks of using Copaxone while breastfeeding are not currently known, the manufacturer recommends using the drug cautiously if you are breastfeeding. Therefore, be sure to talk with your healthcare provider if you take Copaxone and are breastfeeding or are thinking of starting.
No studies have been conducted on whether Copaxone passes through breast milk. The drug is a rather large molecule and is, therefore, unlikely to pass though breast milk. However, once it is broken down in the body, small parts of the molecule could possibly pass through breast milk. Since no studies have been performed, it is impossible to predict exactly what effects (if any) Copaxone may cause in a breastfed infant.
You and your healthcare provider must consider the benefits of Copaxone for you, the benefits of breastfeeding for your baby, and the possible unknown risks of Copaxone for your baby. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Copaxone and breastfeeding that is right for you.